{
    "nctId": "NCT03941756",
    "briefTitle": "Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma",
    "officialTitle": "Prophylactic Lymphovenous Bypass Procedure Following Axillary Lymphadenectomy: A Prospective Observational Study",
    "overallStatus": "RECRUITING",
    "conditions": "Anatomic Stage III Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Locally Advanced Breast Carcinoma, Melanoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 252,
    "primaryOutcomeMeasure": "Volumetric diagnosis of lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients greater than or equal to 18 years of age.\n* Patients willing to participate.\n* Patients able to complete informed consent.\n* Patients will be eligible for inclusion if they fall into one for two groups:\n\n  * Patients with inflammatory breast cancer, and those with locally advanced non-inflammatory breast cancer that are undergoing ALND and are anticipated to receive radiation therapy\n  * Or: Patients with a diagnosis of melanoma (including unknown primary) that will undergo ALND will also be eligible for inclusion in the study as a comparator group.\n\nExclusion Criteria:\n\n* Patients taking anticoagulants within 7 days prior to surgery.\n* Patients that are known to be pregnant at the time of surgery.\n* Patients are available for follow-up less than 18 months or do not undergo measurements within the scheduled period.\n* Patients with body mass index (BMI) greater than 50.0.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}